2820.6000 1.50 (0.05%)
NSE Sep 09, 2025 15:31 PM
Volume: 55,776
 

2820.60
0.05%
Angel Broking
For 2QFY2017, sales stood at Rs783cr vs. Rs700cr expected and vs. Rs700cr in 2QFY2016, a yoy growth of 11.8%. On the operating front, the OPM came in at 15.9% vs. 17.2% in 2QFY2016 and vs. 17.0% expected. The company's OPM was impacted by other expenses, which grew by 40.5% yoy. Thus, the company posted an Adj. net profit of Rs98cr vs. Rs..
GlaxoSmithKline Phar.. has an average target of 2800.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended